FDA Moves To Rein In Drugmakers' Abuse Of Orphan Drug Law
Following an investigation by Kaiser Health News and NPR, the Food and Drug Administration has moved to close a loophole that lets drugmakers skip pediatric testing of drugs to treat rare diseases.